Tissue-specific and paradoxical bile acid–FXR/TGR5 signaling in MASLD: reframing the brain–gut–liver axis
Frontiers in Medicine · 17.11.2026 · 13
DOI: 10.3389/fmed.2026.1990233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 17.11.2026. Verfasst von Yajing Li und 1 weiteren Autor:innen. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gansu University of Chinese Medicine.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a multisystem disorder in which hepatic metabolic injury coexists with intestinal dysbiosis and neurobehavioral abnormalities. Bile acids function not only as digestive molecules but also as inter-organ signals through the nuclear receptor farnesoid X receptor (FXR) and the membrane receptor Takeda G protein-coupled receptor 5 (TGR5). This review reframes the bile acid–FXR/TGR5 pathway from a brain–gut–liver perspective, with particular emphasis on tissue-specific and sometimes paradoxical receptor functions. We summarize hepatic, intestinal, and central FXR/TGR5 signaling; discuss humoral and vagal routes linking the gut–liver axis with the brain; and critically examine conflicting findings arising from model selection, sex, bile acid profiling strategies, and global vs. tissue-specific receptor manipulation. We further reinterpret current therapeutic approaches, including FXR agonists, TGR5 agonists, GLP-1 receptor agonists, and natural products, in terms of tissue selectivity and central exposure. The available evidence supports a shift from indiscriminate receptor activation toward compartment-selective modulation, while also highlighting the need for prospective human studies, multi-tissue omics, and direct assessment of central bile acid signaling.
Förderung
- Gansu University of Chinese Medicine
Zitieren
APA
Li, Y., & Liu, J. (2026). Tissue-specific and paradoxical bile acid–FXR/TGR5 signaling in MASLD: reframing the brain–gut–liver axis. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1990233
Vancouver
Li Y, Liu J. Tissue-specific and paradoxical bile acid–FXR/TGR5 signaling in MASLD: reframing the brain–gut–liver axis. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1990233
BibTeX
@article{Li2026,
author = {Li, Yajing and Liu, Junhong},
title = {Tissue-specific and paradoxical bile acid–FXR/TGR5 signaling in MASLD: reframing the brain–gut–liver axis},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1990233}
}
EUVIMED